Hudson Bay Capital Management »

Immunovant shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $570k 20k 28.51
2023-06-30 $3.5M 185k 18.97

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (NYCB)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Immunovant

Vanguard Group
BlackRock
BlackRock
Armistice Capital
T. Rowe Price Investment Management
Deep Track Capital
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant